• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.

作者信息

Gambichler Thilo, Doerler Martin, Scheel Christina H

机构信息

Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.

出版信息

Lupus. 2021 Mar;30(3):531-533. doi: 10.1177/0961203320983448. Epub 2021 Jan 6.

DOI:10.1177/0961203320983448
PMID:33407044
Abstract
摘要

相似文献

1
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.癌症免疫检查点抑制剂治疗开始后出现亚急性皮肤型红斑狼疮。
Lupus. 2021 Mar;30(3):531-533. doi: 10.1177/0961203320983448. Epub 2021 Jan 6.
2
Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy.帕博利珠单抗治疗后迟发性亚急性皮肤型红斑狼疮
Eur J Cancer. 2021 Mar;145:168-170. doi: 10.1016/j.ejca.2020.12.017. Epub 2021 Jan 21.
3
Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab.帕博利珠单抗诱发的新型皮肤红斑狼疮发病
Acta Derm Venereol. 2024 Sep 30;104:adv40801. doi: 10.2340/actadv.v104.40801.
4
Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor.免疫检查点抑制剂诱发的与系统性红斑狼疮相关的冻疮样狼疮样皮肤反应。
Rheumatology (Oxford). 2021 Dec 24;61(1):e13-e14. doi: 10.1093/rheumatology/keab670.
5
Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.抗程序性细胞死亡蛋白 1 治疗相关的亚急性皮肤型狼疮和皮肌炎。
Br J Dermatol. 2019 Sep;181(3):580-583. doi: 10.1111/bjd.17245. Epub 2018 Dec 10.
6
Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.帕博利珠单抗诱导的伴有黑素细胞清除的亚急性皮肤型红斑狼疮。
J Dermatol. 2020 Jun;47(6):e217-e219. doi: 10.1111/1346-8138.15316. Epub 2020 Mar 15.
7
Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases.帕博利珠单抗治疗晚期黑色素瘤相关皮肤狼疮：三例报告。
Melanoma Res. 2019 Jun;29(3):338-341. doi: 10.1097/CMR.0000000000000587.
8
Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.免疫治疗的晚期非小细胞肺癌患者的心包积液发生率。
Adv Ther. 2020 Jul;37(7):3178-3184. doi: 10.1007/s12325-020-01386-y. Epub 2020 May 20.
9
Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma.免疫检查点抑制剂诱发黑色素瘤患者出现类伏格特-小柳-原田综合征
Clin Exp Dermatol. 2020 Oct;45(7):908-911. doi: 10.1111/ced.14282. Epub 2020 Jul 5.
10
Pembrolizumab in the Treatment of Breast Cancer.帕博利珠单抗治疗乳腺癌
N Engl J Med. 2022 Jul 21;387(3):273-274. doi: 10.1056/NEJMe2207532.

引用本文的文献

1
Case Report: Subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody camrelizumab combined with chemotherapy.病例报告：抗程序性死亡蛋白1（PD-1）抗体卡瑞利珠单抗联合化疗诱发亚急性皮肤型红斑狼疮
Front Immunol. 2025 Mar 28;16:1539373. doi: 10.3389/fimmu.2025.1539373. eCollection 2025.
2
Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab.帕博利珠单抗诱发的新型皮肤红斑狼疮发病
Acta Derm Venereol. 2024 Sep 30;104:adv40801. doi: 10.2340/actadv.v104.40801.
3
Immune Checkpoint Inhibitors and Lupus Erythematosus.
免疫检查点抑制剂与红斑狼疮
Pharmaceuticals (Basel). 2024 Feb 15;17(2):252. doi: 10.3390/ph17020252.
4
Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literature.免疫检查点抑制剂诱发的亚急性皮肤型红斑狼疮：一例报告并文献复习
Front Med (Lausanne). 2024 Feb 1;11:1334718. doi: 10.3389/fmed.2024.1334718. eCollection 2024.
5
The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus-A Pilot Study.血清可溶性程序性死亡配体1水平降低在盘状红斑狼疮中的可能临床意义，而非亚急性皮肤型红斑狼疮——一项初步研究
J Clin Med. 2023 Aug 30;12(17):5648. doi: 10.3390/jcm12175648.